Attucci, I.; Peruzzi, B.; Nozzoli, C.; Guerrieri, S.; Pilerci, S.; Boncompagni, R.; Urbani, S.; Orazzini, C.; Bencini, S.; Capone, M.;
et al. Combined Minimal Residual Disease Evaluation in Bone Marrow and Apheresis Samples in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Improves Outcome Prediction. Cancers 2025, 17, 2439.
https://doi.org/10.3390/cancers17152439
AMA Style
Attucci I, Peruzzi B, Nozzoli C, Guerrieri S, Pilerci S, Boncompagni R, Urbani S, Orazzini C, Bencini S, Capone M,
et al. Combined Minimal Residual Disease Evaluation in Bone Marrow and Apheresis Samples in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Improves Outcome Prediction. Cancers. 2025; 17(15):2439.
https://doi.org/10.3390/cancers17152439
Chicago/Turabian Style
Attucci, Irene, Benedetta Peruzzi, Chiara Nozzoli, Serena Guerrieri, Sofia Pilerci, Riccardo Boncompagni, Serena Urbani, Chiara Orazzini, Sara Bencini, Manuela Capone,
and et al. 2025. "Combined Minimal Residual Disease Evaluation in Bone Marrow and Apheresis Samples in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Improves Outcome Prediction" Cancers 17, no. 15: 2439.
https://doi.org/10.3390/cancers17152439
APA Style
Attucci, I., Peruzzi, B., Nozzoli, C., Guerrieri, S., Pilerci, S., Boncompagni, R., Urbani, S., Orazzini, C., Bencini, S., Capone, M., Messeri, M., Caporale, R., Annunziato, F., Vannucchi, A. M., & Antonioli, E.
(2025). Combined Minimal Residual Disease Evaluation in Bone Marrow and Apheresis Samples in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Improves Outcome Prediction. Cancers, 17(15), 2439.
https://doi.org/10.3390/cancers17152439
